Today's episode on Redefining Medicine features Alex Zhavoronkov, PhD. As CEO of Insilico Medicine, Zhavoronkov is a pioneer in artificial intelligence, deep learning techniques, and blockchain technologies for drug discovery and biomarker development. With a long-held belief that the issue of aging needs to be further researched and addressed, Zhavoronkov seeks to discover how precision medicine can further advance treatment protocols for patients. Through research focuses on genomics, epigenetics, and personalized screening techniques, Zhavoronkov works on advancing Regenerative and Anti-Aging Medicine with the most cutting-edge technologies and clinical research.
Don't miss out on more Redefining Medicine podcast - Subscribe today and say hello to us on social media! Email us at firstname.lastname@example.org
The views and opinions expressed on this program are those of the persons appearing on the program and do not necessarily reflect the views and opinions of The American Academy of Anti-Aging Medicine A4M/MMI™